TECNIS ODYSSEY TORIC II IOL DRT225 (REF DRT2250190)Recalls & reported problems
Johnson & Johnson Surgical Vision, Inc. · TEC ODYSSEY TOR II SMPCY 19.0D CYL2.25 · Class 3 · Implant
All models of TECNIS ODYSSEY TORIC II IOL (106)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 05050474811928), received between Feb 3, 2025 and Oct 29, 2025 — classified as 2 injuries, 2 malfunctions.
The most frequently reported specific device problem is “Break” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Break2
- Device Difficult to Setup or Prepare1
Patient problems
- Flashers2
- Halo2
- No Clinical Signs, Symptoms or Conditions2
- Visual Disturbances1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryOct 29, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PRELOADED MULTIFOCAL TORIC INTRAOCULAR LENS (IOL) WAS EXPLANTED FROM THE RIGHT EYE DUE TO THE PATIENT¿S COMPLAINTS OF INCREASED GLARE, HALOS, AND STARBURSTS WHILE DRIVING AT NIGHT. THE ISSUE WAS FIRST IDENTIFIED DURING A POST-OPERATIVE EXAMINATION. ANOTHER JOHNSON & JOHNSON LENS WAS IMPLANTED AS REPLACEMENT; DIU225 19.0 DIOPTER. THERE WERE NO UNPLANNED COMPLICATIONS, SUCH AS INCISION ENLARGEMENT, SUTURES, OR VITRECTOMY. NO MEDICAL ATTENTION OR MEDICATION OUTSIDE STANDARD OF CARE WAS REQUIRED AND THERE WERE NO SURGICAL DELAYS. THE PATIENT IS FULLY RECOVERED. DAILY ACTIVITIES ARE NOT AFFECTED. PRE-OPERATIVE BEST SPECTACLE CORRECTED VISUAL ACUITY (BSCVA) WAS 20/20-2 AND POST-OPERATIVE BSCVA WAS 20/20+1. IT WAS REPORTED THAT THE DIRECTIONS FOR USE WERE FOLLOWED. NO FURTHER INFORMATION WAS PROVIDED.
Patient problems: Flashers; Halo; Visual Disturbances
MAUDE report 23416781 ↗InjurySep 2, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A PATIENT IMPLANTED WITH A TECNIS TORIC ODYSSEY INTRAOCULAR LENS (IOL) ON (B)(6) 2024, COMPLAINED OF VISUAL DISTURBANCES SUCH AS DIFFICULTY DRIVING AT NIGHT, GHOSTING, AND HALOS. THE PATIENT¿S PRE-OPERATIVE BEST SPECTACLE CORRECTED VISUAL ACUITY WAS 20/20-1, AND HER POST-OPERATIVE BEST SPECTACLE CORRECTED VISUAL ACUITY WAS 20/25+1. ON (B)(6) 2025, THE LENS WAS EXPLANTED DURING A SECONDARY SURGERY. THE PROCEDURE WAS COMPLETED WITHOUT COMPLICATIONS, SUCH AS UNPLANNED INCISION ENLARGEMENT, SUTURES, VITRECTOMY, OR PROCEDURAL DELAYS. THE PATIENT WAS FULLY RECOVERED. NO FURTHER INFORMATION IS AVAILABLE.
Patient problems: Flashers; Halo
MAUDE report 22948722 ↗MalfunctionAug 23, 2025Break; Break
IT WAS REPORTED THAT THE JOHNSON AND JOHNSON (JNJ) INTRAOCULAR LENS (IOL) WAS CRACKED. THE IOL WAS PARTIALLY INSERTED AND THEN REMOVED BECAUSE MULTIPLE CRACKS WERE NOTICED ON THE OPTIC. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITH A REPLACEMENT IOL OF THE SAME MODEL AND DIOPTER. THERE WAS NO PATIENT INJURY, NO VITRECTOMY, SUTURES AND INCISION ENLARGEMENT. REPORTEDLY, THE PATIENT IS DOING WELL. NO FURTHER INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22881327 ↗MalfunctionFeb 3, 2025Break; Device Difficult to Setup or Prepare; Break; Device Difficult to Setup or Prepare
IT WAS REPORTED THAT THE PRELOADED LENS WAS DIFFICULT TO ADVANCE, ADVANCED VERY QUICKLY AND CAME OUT IN MULTIPLE PARTS DURING INSERTION INTO THE EYE, LEADING TO PATIENT CONTACT WITH THE IOL. THE LENS WAS SUBSEQUENTLY REPLACED WITH THE SAME MODEL DIOPTER IOL DURING THE SAME PROCEDURE. THE PATIENT IS NOW SATISFIED WITH THEIR VISION, WHICH IS 20/15. NO INJURY OR ADDITIONAL INTERVENTION WAS REQUIRED. NO FURTHER INFORMATION IS AVAILABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21298475 ↗
Other Lens, multifocal intraocular devices
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular144 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular1 recall66 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular113 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular112 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular110 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular107 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular104 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular93 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page